top of page
image_5e7311c0.png

Neurofeedback

This therapy measures brainwave activity in real-time and provides visual or auditory feedback to the individual. By observing this, individuals can train their brainwave patterns to manage neurological conditions.

Evidence-based neurofeedback uses real‑time brain‑activity monitoring to help your nervous system learn more efficient patterns. It is one of the core modalities in our program, and an area where Dr. Sarah Prinsloo brings nationally recognized expertise. As a Board Member of the Biofeedback Certification International Alliance (BCIA), she helps set the training and certification standards used across the field. This ensures that your care is guided by the highest level of professional competency and ethical practice.  We use neurofeedback to support:

  • Anxiety and stress regulation

  • Depression and mood stability

  • Cognitive clarity

  • Pain‑related nervous‑system dysregulation

 

Unlike approaches that rely on simple protocol matching, our neurofeedback plans are built from a holistic interpretation of your qEEG, sensory profile, cognitive function, and emotional patterns. This allows us to target the networks most relevant to your symptoms and track meaningful change over time.

Take the First Step

Are you looking for relief from your symptoms but not sure if our drug-free, non-invasive therapies can help?  Book a free 15 minute consultation with Dr Prinsloo to see how we can help you.

Dr Sarah Prinsloo

What Is Neurofeedback? The Longer Story

Neurofeedback is a non-invasive therapeutic technique that trains individuals to self-regulate their brainwave activity. Sensors placed on the scalp measure electrical activity in real time. A computer then translates this data into immediate visual or auditory rewards (e.g., a movie playing smoothly or music getting louder) when the brain enters a desired, healthier state. Through operant conditioning, the brain naturally learns to replicate these optimal neural patterns. [1, 2]

 

History and Development [3]

  • Discovery of Brainwaves (1920s): German psychiatrist Hans Berger recorded the first human electroencephalogram (EEG). He identified the alpha rhythm, proving the brain emits continuous electrical activity. 

  • The Founders (Late 1950s–1960s): Dr. Joe Kamiya at the University of Chicago demonstrated that humans could consciously alter their alpha waves through a simple reward system using a bell tone. Simultaneously, Dr. Barry Sterman showed that cats trained to alter their sensorimotor rhythm (SMR) brainwaves became highly resistant to rocket-fuel-induced seizures. This research was adapted by NASA to train astronauts for concentration, stress management and toxicity effects. 

  • Clinical Application (1970s): Dr. Sterman successfully replicated his findings in human epilepsy patients. Soon after, Dr. Joel Lubar applied neurofeedback to manage Attention-Deficit/Hyperactivity Disorder (ADHD), laying the foundation for modern protocol variations. [4]

  • Technological Expansion (1990s–Present): The integration of high-speed computers and Quantitative EEG (qEEG) allowed clinicians to "map" individual brain dysfunctions and design hyper-personalized training.

Strengths

  • Long-Term Remodeling: Unlike medication, which only masks symptoms while active, neurofeedback relies on neuroplasticity. It aims to alter core brain wiring, offering sustained benefits years after sessions conclude.

  • Drug-Free Alternative: It provides a highly effective option for patients who cannot tolerate or prefer to avoid the side effects of pharmaceuticals.

  • Personalized Approach: Using advanced diagnostic tools like QEEG, treatments are tailored precisely to an individual's specific neural imbalances rather than broad diagnostic labels.

  • Empowers Self-Regulation: It acts as a mirror that teaches the brain to unconsciously self-correct during real-world stressors.

 

Weaknesses

  • Practitioner Dependent: Results can be strongly dependent on the therapist should understand and follow the brain activity changes during treatment, continually adjusting the reward for optimum learning.  Selecting the right practitioner is important since the practice is still lightly regulated. Look for a professional certified by an organization like the Biofeedback Certification International Alliance BCIA [2].

  • Financial Cost: A complete treatment protocol typically requires 20 to 40 sessions, which if done well, needs supervision and refinement from a practitioner.  Some traditional medical insurance does not fully cover these costs.

  • Time Commitment: Patients must commit to completing the sessions multiple times a week.  Since it is a learning process, interruptions to treatment before the program is complete means that the new patterns are not fully "learned".  

  • Mild Side Effects: While generally safe, some individuals experience transient fatigue, brain fog, mild headaches, or temporary anxiety spikes directly following treatment sessions.

References

[1] Marzbani H, Marateb HR, Mansourian M. Neurofeedback: A Comprehensive Review on System Design, Methodology and Clinical Applications. Basic Clin Neurosci. 2016 Apr;7(2):143-58. doi: 10.15412/J.BCN.03070208. PMID: 27303609; PMCID: PMC4892319.  https://pmc.ncbi.nlm.nih.gov/articles/PMC4892319/

[2] https://www.psychologytoday.com/us/therapy-types/neurofeedback

 

[3] https://neurofeedback-luxembourg.com/the-comprehensive-neurofeedback-history-understanding-its-impact-and-evolution/

 

[4] Jubair H, Mehenaz M, Islam MM, Yeasmin N. Neurofeedback: Applications, advancements, and future directions. PCN Rep. 2025 Dec 25;4(4):e70259. doi: 10.1002/pcn5.70259. PMID: 41459375; PMCID: PMC12741318.  

https://pmc.ncbi.nlm.nih.gov/articles/PMC12741318/

[5] Prinsloo S, Kaptchuk TJ, De Ridder D, Lyle R, Bruera E, Novy D, Barcenas CH, Cohen LG. Brain-computer interface relieves chronic chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled trial. Cancer. 2024 Jan;130(2):300-311. doi: 10.1002/cncr.35027. Epub 2023 Sep 21. PMID: 37733286. 

https://pubmed.ncbi.nlm.nih.gov/37733286/

[6] Prinsloo S, Novy D, Driver L, Lyle R, Ramondetta L, Eng C, Lopez G, Li Y, Cohen L. The Long-Term Impact of Neurofeedback on Symptom Burden and Interference in Patients With Chronic Chemotherapy-Induced Neuropathy: Analysis of a Randomized Controlled Trial. J Pain Symptom Manage. 2018 May;55(5):1276-1285. doi: 10.1016/j.jpainsymman.2018.01.010. Epub 2018 Feb 5. PMID: 29421164.  

https://pubmed.ncbi.nlm.nih.gov/29421164/

[7] Prinsloo S, Gabel S, Lyle R, Cohen L. Neuromodulation of cancer pain. Integr Cancer Ther. 2014 Jan;13(1):30-7. doi: 10.1177/1534735413477193. Epub 2013 Feb 25. PMID: 23439659.  

https://pubmed.ncbi.nlm.nih.gov/23439659/

Content reviewed by: Dr Sarah Prinsloo, PhD

Last Updated: June 2026

bottom of page